Radiolabeled somatostatin-derived peptides for imaging and therapeutic
uses
    3.
    发明授权
    Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses 失效
    放射性标记的生长抑素衍生肽用于成像和治疗用途

    公开(公告)号:US6051206A

    公开(公告)日:2000-04-18

    申请号:US592323

    申请日:1996-05-06

    IPC分类号: A61K51/08 A61K51/00 A61M36/14

    摘要: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agent Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.

    摘要翻译: PCT No.PCT / US94 / 06274 Sec。 371日期:1996年5月6日 102(e)日期1996年5月6日PCT提交1994年6月3日PCT公布。 公开号WO95 / 00553 日期1995年1月5日本发明涉及治疗试剂和肽,包括放射治疗试剂和肽,放射诊断试剂和肽,以及用于制备标记的放射诊断剂的方法。 具体地,本发明涉及生长抑素的环肽衍生物和类似物,以及用放射性同位素放射性标记的这种肽的实施方案,以及用于制备放射性标记和用于放射诊断和放射治疗目的的这些肽的方法和试剂盒。 本发明具体涉及用锝-99m放射性标记的生长抑素的环肽衍生物和类似物及其用作闪烁照相成像剂。 本发明还具体涉及用作放射性治疗剂放射性标记的细胞毒性放射性同位素如铼-186(186Re)和铼-188(188Re)的生长抑素的环肽衍生物和类似物用于制造,放射性标记和使用这些肽的方法和试剂盒, 还提供了哺乳动物体内的治疗。

    Radiolabeled somatostatin receptor-binding peptides
    4.
    发明授权
    Radiolabeled somatostatin receptor-binding peptides 失效
    放射标记生长抑素受体结合肽

    公开(公告)号:US6017509A

    公开(公告)日:2000-01-25

    申请号:US92355

    申请日:1993-07-15

    摘要: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.

    摘要翻译: 本发明涉及治疗试剂和肽,包括放射治疗试剂和肽,放射诊断试剂和肽,以及用于制备标记的放射诊断剂的方法。 具体地,本发明涉及生长抑素的环肽衍生物和类似物,以及用放射性同位素放射性标记的这种肽的实施方案,以及用于制备放射性标记和用于放射诊断和放射治疗目的的这些肽的方法和试剂盒。 本发明具体涉及用锝-99m放射性标记的生长抑素的环肽衍生物和类似物及其用作闪烁照相成像剂。 本发明还具体涉及放射性标记的细胞毒性放射性同位素如铼-186(186Re)和铼-188(188Re)用作放射治疗剂的生长抑素的环肽衍生物和类似物。 还提供了用于在哺乳动物体内制造,放射性标记和诊断和治疗上使用这些肽的方法和试剂盒。

    Radiolabeled peptides
    7.
    发明授权
    Radiolabeled peptides 失效
    放射性标记肽

    公开(公告)号:US6017512A

    公开(公告)日:2000-01-25

    申请号:US931095

    申请日:1997-09-15

    摘要: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.

    摘要翻译: 本发明涉及治疗试剂和肽,包括放射治疗试剂和肽,放射诊断试剂和肽,以及用于制备标记的放射诊断剂的方法。 具体地,本发明涉及生长抑素的环肽衍生物和类似物,以及用放射性同位素放射性标记的这种肽的实施方案,以及用于制备放射性标记和用于放射诊断和放射治疗目的的这些肽的方法和试剂盒。 本发明具体涉及用锝-99m放射性标记的生长抑素的环肽衍生物和类似物及其用作闪烁照相成像剂。 本发明还具体涉及放射性标记的细胞毒性放射性同位素如铼-186(186Re)和铼-188(188Re)用作放射治疗剂的生长抑素的环肽衍生物和类似物。 还提供了用于在哺乳动物体内制造,放射性标记和诊断和治疗上使用这些肽的方法和试剂盒。

    Cyclic hexapeptide somatostatin analogues
    10.
    发明授权
    Cyclic hexapeptide somatostatin analogues 失效
    循环六肽生长抑素类似物

    公开(公告)号:US5955426A

    公开(公告)日:1999-09-21

    申请号:US776160

    申请日:1997-06-30

    摘要: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, and radiodiagnostic reagents and peptides. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes.

    摘要翻译: PCT No.PCT / US95 / 09276 Sec。 371日期:1997年6月30日 102(e)日期1997年6月30日PCT提交1995年7月20日PCT公布。 公开号WO96 / 04308 日期1996年2月15日本发明涉及治疗试剂和肽,包括放射治疗试剂和肽,以及放射诊断试剂和肽。 具体而言,本发明涉及生长抑素的环肽衍生物和类似物以及放射性标记的放射性物质的这些肽的实施方案,以及使用这些肽用于放射诊断和放射治疗目的的方法。